CervoMed Inc. (CRVO)
NASDAQ·Healthcare·Biotechnology
$3.80
-0.52%
Mkt Cap $42.01M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | $90.84K | $6.51K | -92.83% | -$0.79 | -$0.88 | -11.39% | — | — |
| Q4 2025 Nov 7, 2025 | $842.86K | $322.57K | -61.73% | -$0.68 | -$0.84 | -23.53% | — | — |
| Q3 2025 Aug 8, 2025 | $1.43M | $1.76M | +22.63% | -$0.57 | -$0.70 | -22.81% | — | — |
| Q2 2025 May 12, 2025 | $1.47M | $1.92M | +30.69% | -$0.60 | -$0.56 | +6.67% | — | — |
| Q1 2025 Mar 17, 2025 | $1.54M | $2.16M | +40.36% | -$0.67 | -$0.80 | -19.40% | — | — |
| Q4 2024 Nov 12, 2024 | $1.82M | $1.94M | +6.65% | -$0.41 | -$0.55 | -34.15% | — | — |
| Q3 2024 Aug 9, 2024 | $2.20M | $3.29M | +49.50% | -$0.24 | -$0.27 | -12.50% | — | — |
| Q2 2024 May 14, 2024 | $1.35M | $2.35M | +73.87% | -$0.46 | -$0.41 | +10.87% | — | — |
| Q1 2024 Mar 25, 2024 | $2.00M | $2.49M | +24.53% | -$0.29 | -$0.38 | -31.03% | — | — |
| Q4 2023 Nov 13, 2023 | — | $1.53M | — | -$0.95 | -$0.70 | +26.32% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$2.90 | -$1.04 | +64.08% | — | — |
| Q2 2023 May 15, 2023 | — | $1.41M | — | -$2.87 | -$3.01 | -5.04% | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | -$3.30 | -$3.00 | +9.15% | — | — |
| Q3 2022 Sep 29, 2022 | — | — | — | -$3.09 | -$2.06 | +33.38% | — | — |
| Q2 2022 Jun 29, 2022 | — | — | — | — | -$3.08 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$3.06 | -$3.33 | -8.86% | — | — |
| Q4 2021 Dec 30, 2021 | — | — | — | — | -$2.56 | — | — | — |
| Q3 2021 Sep 29, 2021 | — | — | — | — | -$8.98 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$2.78 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$4.22 | — | — | — |